← Alle mensen

DH

Dok Hyun Yoon

4 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymp...

Lancet (London, England) · 10 januari 2026

Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B...

Lancet (London, England) · 16 november 2024

Golidocitinib (selectieve JAK1-remmer) bij refractair/recidief perifeer T-cellymfoom

The Lancet. Oncology · 2024-01

Lenalidomide plus R-CHOP versus R-CHOP bij onbehandeld DLBCL: ROBUST fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 april 2021